Tetrabenazine
- Molecular formula
- C19H22Cl3NO4
- CAS Number
- 102601-59-6
- IUPAC Name
- 1-[2-(3,4-dichlorophenyl)sulfinylethyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium;chloride
- Molecular Weight
- 375.25g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3000g/cm3
- Synonyms
- 22336-78-3
Identification
Interesting Facts about 1-[2-(3,4-Dichlorophenyl)sulfinylethyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium; chloride
The compound 1-[2-(3,4-dichlorophenyl)sulfinylethyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium; chloride belongs to an intriguing class of molecules known as isoquinolines. These compounds are noted for their vast range of biological activities, making them of great interest in medicinal chemistry.
Key Characteristics
- Isoquinoline Framework: The isoquinoline structure is foundational in numerous pharmacological agents, contributing to their efficacy in treating various diseases.
- Sulfinyl Group: The presence of a sulfinyl group in this compound can enhance its reactivity, potentially leading to unique interactions in biological systems.
- Chlorinated Phenyl Ring: The dichlorophenyl moiety significantly impacts the compound's electronic properties, which may influence its interaction with biological targets.
This compound is especially noteworthy due to its potential as a therapeutic agent. Researchers are exploring its application in treating conditions related to:
- Cancer: The bioactivity associated with isoquinolines could be pivotal in developing anti-cancer drugs.
- Nervous System Disorders: Compounds with similar structures have shown promises as neuroprotective agents.
- Inflammatory Diseases: Potential anti-inflammatory properties open avenues for managing chronic conditions.
Moreover, the compound’s unique functional groups afford opportunities for further modifications, leading to new derivatives with possibly enhanced therapeutic profiles. As stated by researchers, “The importance of structural diversity in drug design cannot be overstated, as it allows for the honing of specific activities while minimizing side effects.”
In summary, 1-[2-(3,4-dichlorophenyl)sulfinylethyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium; chloride exemplifies the intricate relationship between chemical structure and biological activity, reinforcing the exciting potential of isoquinoline derivatives in modern drug discovery.